Skip to main content
Clinical Trials/NCT01028898
NCT01028898
Unknown
Not Applicable

Screening and Identification of Abnormal Expression Proteins and miRNA From Colonic Mucosa of Patients With Irritable Bowel Syndrome.

Chinese PLA General Hospital0 sites180 target enrollmentJanuary 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Irritable Bowel Syndrome
Sponsor
Chinese PLA General Hospital
Enrollment
180
Last Updated
15 years ago

Overview

Brief Summary

In the investigators study, the investigators will focus on the screening of the related proteins and miRNA to IBS in order to reveal the possible clues or molecular mechanism for this disorder.

Detailed Description

For the proteomic procedures, Our study groups extracted proteins from the cecum and sigmoid colon samples and ran on the two-dimensional gel electrophoresis (2-DE). The proteins on 2-DE were visualized by the silver stain, and then gel maps were scanned and analyzed with the Image Master 2D Elite. The obvious abnormal protein spots were identified by the mass spectrometry. Western blot 、 immunohistochemistry 、 mRNA and miRNA were also performed for further verification of the proteins.

Registry
clinicaltrials.gov
Start Date
January 2006
End Date
December 2012
Last Updated
15 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese PLA General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with symptoms meeting Rome III criteria for diagnosis of IBS-C and IBS-D

Exclusion Criteria

  • Patients with organic illnesses or a history of major abdominal surgery
  • Major psychotic episode, mental retardation or dementia
  • Pregnant women and lactational women
  • Postinfectious IBS, PI-IBS

Outcomes

Primary Outcomes

Not specified

Similar Trials